Preoperative Nomograms and Artificial Neural Networks (ANNs) for Identification of Surgical Candidates

Abstract Selection of prostate cancer risk patients for surgical treatment has traditionally been accomplished by the creation of risk groups, like clinical stage, prostate specific antigen and others. Using these data knowledge-based expert systems were created. Among these the most popular model is the logistic regression model. Ideally, this prediction should be as accurate as possible. Many studies have shown that even expert on its field often are incorrect compared to the validated nomograms and artifical neural networks (ANNs) presented herein. Nomograms are instruments that predict outcomes for the individual patient using algorithms that incorporate multiple variables. Nomograms consist of a set of axes. Each variable is represented by a scale, with each value of that variable corresponding to a specific number of points according to its prognostic impact. In a final pair of axes, the total point value from all he variables is converted to the probability of reaching the end point By using scales, nomograms calculate the continuous probability of a certain outcome, resulting in more accurate predictions than models based on risk grouping. ANNs has gained increasing popularity and are the most popular artificial learning tool in biotechnology. This technique can roughly be described as a universal algebraic function that will distinguish dependency between dependent and independent variables, which is either unknown or very complex. The application of ANNs to complex relationships makes them highly attractive for the study of complexed medical decisions like predicting pathological stage or local recurrence after radical prostatectomy (RPE). Accuracy of nomograms and ANNs for pathological staging and PSA recurrence varies between 72–88.3% versus 77–91%, and 75–81% and 67–83%, respectively.

[1]  M. Kattan,et al.  Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. , 1998, Human pathology.

[2]  M W Kattan,et al.  Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Partin,et al.  Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma , 2001, Cancer.

[4]  M W Kattan,et al.  A catalog of prostate cancer nomograms. , 2001, The Journal of urology.

[5]  A W Partin,et al.  A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy. , 2000, Urology.

[6]  A. Zlotta,et al.  129 PSA molecular forms and indices for early detection of prostate cancer in men with total PSA between 2.0 and 4.0 ng/ml: final results of the EPCD study , 2004 .

[7]  J. Blasko,et al.  Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. , 2001, Urology.

[8]  W. Catalona,et al.  Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. , 1994, The Journal of urology.

[9]  D. E. Neal,et al.  Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study. , 1998, British Journal of Cancer.

[10]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[11]  Pierre I Karakiewicz,et al.  International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Mesut Remzi,et al.  An artificial neural network to predict the outcome of repeat prostate biopsies. , 2003, Urology.

[13]  R W Veltri,et al.  Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. , 1999, Urology.

[14]  A W Partin,et al.  Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. , 2000, The Journal of urology.

[15]  Hartwig Huland,et al.  Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. , 2003, The Journal of urology.

[16]  E J Gamito,et al.  Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study. , 2001, Molecular urology.

[17]  Mesut Remzi,et al.  Artificial neural networks for decision-making in urologic oncology. , 2003, Reviews in urology.

[18]  Mesut Remzi,et al.  Novel artificial neural network for early detection of prostate cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  P. Kantoff,et al.  Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Mesut Remzi,et al.  PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium. , 2003, European urology.

[21]  A W Partin,et al.  Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. , 2002, Urology.

[22]  J. Bishoff,et al.  Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. , 2003, Urology.

[23]  Mesut Remzi,et al.  An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less. , 2003, The Journal of urology.

[24]  M. Kattan,et al.  Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. , 2004, The Journal of urology.

[25]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[26]  Kevin Regan,et al.  Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  A. D'Amico,et al.  A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.

[28]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[29]  A W Partin,et al.  Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer. , 2001, Urology.

[30]  Michael W. Kattan,et al.  Expert Systems in Medicine , 2001 .

[31]  E. Crawford,et al.  Impact of different variables on the outcome of patients with clinically confined prostate carcinoma: prediction of pathologic stage and biochemical failure using an artificial neural network. , 2001, Cancer.

[32]  Mesut Remzi,et al.  Artificial Neural Networks in Urology 2004 , 2004 .

[33]  Victor Reuter,et al.  A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. , 2003, The Journal of urology.

[34]  Thomas M. Wheeler,et al.  A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer , 1998 .

[35]  M. Brawer,et al.  Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint® scintiscans , 2000, The Prostate.

[36]  U Pichlmeier,et al.  A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. , 2001, The Journal of urology.

[37]  Michael W Kattan,et al.  Prediction of progression: nomograms of clinical utility. , 2002, Clinical prostate cancer.

[38]  E D Crawford,et al.  Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy. , 2000, Techniques in urology.

[39]  Michael W Kattan,et al.  A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. , 2003, The Journal of urology.